Exploring the Therapeutic Potential of Evodia rutaecarpa in Early-Onset Pancreatic Cancer: A Network Pharmacology and Molecular Docking Approach
These outcomes provide novel insights into the prevention and treatment of PC, presenting Evodia rutaecarpa as a promising candidate for further experimental validation and clinical exploration. The identified discovery has the potential to reduce the drug resistance of Evodia rutaecarpa by engaging with a new target in a specific manner, thus improving therapeutic effectiveness.
Authors
- Han Na Kang (ORCID: https://orcid.org/0009-0006-5022-774X)
- Bonglee Kim (ORCID: https://orcid.org/0000-0002-8678-156X)
- Moon Nyeo Park (ORCID: https://orcid.org/0000-0002-9276-3894)
- Kazi Mehetazul Islam
- Md. Habibur Rahman (ORCID: https://orcid.org/0000-0002-0137-3322)
- MM Rahman (ORCID: https://orcid.org/0000-0002-2353-6823)
- Md Imran Hasan
- Seungjoon Moon
- Md. Nahid Hasan (ORCID: https://orcid.org/0009-0007-8830-3303)
Institutions
- Texas A&M University – San Antonio (US)
- Kyung Hee University (KR)
- Islamic University (BD)
- Korea Institute of Oriental Medicine (KR)
- The University of Texas at San Antonio (US)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-05-05
- DOI
- https://doi.org/10.2174/0113816128356225250305081937
- Citations
- 2
- Primary Topic
- Quinazolinone synthesis and applications
- Type
- article
- Field-Weighted Citation Impact
- 1.87